{
  "id": 487,
  "text": "The presence or absence of LVSI should also be considered for treatment decision.LVSI has been reported as strong predictor of LN involvement for T1a1 cervical cancer patients.LN involvement is reported of low incidence for patients with T1a disease.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: The presence or absence of LVSI should also be considered for treatment decision.LVSI has been reported as strong predictor of LN involvement for T1a1 cervical cancer patients.LN involvement is reported of low incidence for patients with T1a disease.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在针对T1a1期宫颈癌患者制定治疗方案时，是否存在淋巴管侵犯（LVSI）对于评估淋巴结受累风险具有重要预测价值。研究表明，淋巴管侵犯是T1a1期宫颈癌患者淋巴结受累的强预测因子，因此，在制定治疗计划时，应综合考虑LVSI的存在与否。尽管T1a期疾病的总体淋巴结受累风险较低，但若存在LVSI，可能会显著增加淋巴结转移的可能性。因此，临床上需特别关注具有LVSI的患者，以便更加精准地评估风险并制定个体化的治疗方案。",
  "query": "\"在针对T1a1期宫颈癌患者制定治疗方案时，应如何看待LVSI的存在与否对淋巴结受累风险的预测价值？\"",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: \"在针对T1a1期宫颈癌患者制定治疗方案时，应如何看待LVSI的存在与否对淋巴结受累风险的预测价值？\"\n\n<reference text>: The presence or absence of LVSI should also be considered for treatment decision.LVSI has been reported as strong predictor of LN involvement for T1a1 cervical cancer patients.LN involvement is reported of low incidence for patients with T1a disease.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在针对T1a1期宫颈癌患者制定治疗方案时，是否存在淋巴管侵犯（LVSI）对于评估淋巴结受累风险具有重要预测价值。研究表明，淋巴管侵犯是T1a1期宫颈癌患者淋巴结受累的强预测因子，因此，在制定治疗计划时，应综合考虑LVSI的存在与否。尽管T1a期疾病的总体淋巴结受累风险较低，但若存在LVSI，可能会显著增加淋巴结转移的可能性。因此，临床上需特别关注具有LVSI的患者，以便更加精准地评估风险并制定个体化的治疗方案。"
}